SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-023119
Filing Date
2017-04-12
Accepted
2017-04-12 17:01:44
Documents
64
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a17-8935_110q.htm 10-Q 627567
2 EX-31.1 a17-8935_1ex31d1.htm EX-31.1 12058
3 EX-31.2 a17-8935_1ex31d2.htm EX-31.2 9638
4 EX-32.1 a17-8935_1ex32d1.htm EX-32.1 5047
5 EX-32.2 a17-8935_1ex32d2.htm EX-32.2 4963
  Complete submission text file 0001104659-17-023119.txt   4448873

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ctrv-20170331.xml EX-101.INS 883413
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctrv-20170331.xsd EX-101.SCH 56106
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ctrv-20170331_cal.xml EX-101.CAL 38143
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ctrv-20170331_def.xml EX-101.DEF 223606
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT ctrv-20170331_lab.xml EX-101.LAB 448837
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctrv-20170331_pre.xml EX-101.PRE 330753
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36856 | Film No.: 17758508
SIC: 2834 Pharmaceutical Preparations